therainnova AG provides strategic and operational regulatory affairs consulting for the biopharmaceutical industry in Europe. With expert leadership and a strong partner network, we offer end-to-end regulatory support, including due diligence, to maximize portfolio value.
Products, services, technology
Regulatory Roadmaps, Strategic Advice, Health Authority Interactions (Orphan Drug Submissions, Marketing Authorisation Applications, Scientific Advice, SME status, etc).
- https://therainnova.com/
- +41 78 951 9929
- Send an email
Some insights
We help innovative medicines reach patients faster by simplifying complex EU and Swiss regulatory pathways and de risking development programs through senior regulatory leadership and execution.
We deliver senior, hands on regulatory leadership without bureaucracy, enabling small and mid size biotech companies to succeed in highly complex regulatory environments.
Biotech leaders and regulatory professionals who combine scientific excellence, integrity, and patient focus with pragmatic execution and collaboration.
Strengths are deep EU and Swiss regulatory expertise, senior ownership, and flexible execution. Future skills include advanced CMC strategy, digital tools, and regulatory intelligence.
She helps scientists turn their ideas into approved medicines by guiding companies through complex rules and talking to health authorities.
By facilitating networking with innovative biotech companies, investors, and strategic partners and increasing visibility of Swiss regulatory expertise globally.
Swiss and international biotech companies, investors, VC operating partners, and service providers active in late stage development and market access.
